#United States #New York #The Gross Law #aTyr Pharma #Efzofitimod

Filing of Securities Class Action for aTyr Pharma, Inc. Shareholders By The Gross Law Firm

The Gross Law Firm Files Class Action for aTyr Pharma, Inc. Shareholders

On November 24, 2025, The Gross Law Firm issued an important notice for shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR). This announcement pertains to a class action lawsuit that has been initiated on behalf of all individuals who purchased shares of aTyr during a specified time frame, specifically from November 7, 2024, to September 12, 2025. Shareholders who bought shares during this period are encouraged to reach out to the firm for possible lead plaintiff appointments. Significantly, becoming a lead plaintiff isn't a prerequisite for participating in any potential recovery.

Allegations of Deceit

The lawsuit's allegations arise from claims that the company's executives provided investors with excessively optimistic statements regarding the drug Efzofitimod, while simultaneously concealing critical adverse information. The lawsuit specifically addresses the drug's purported ability to allow patients to fully taper off their steroid usage. These claims were challenged when aTyr announced on September 15, 2025, that the EFZO-FIT study, pivotal to its approval, had failed to meet its main objective in assessing the change in mean daily Oral Steroid Consumption (OSC) dose after 48 weeks.

The announcement of these disappointing topline results precipitated a dramatic decline in aTyr’s stock price. Following this disclosure, the closing share price plummeted from $6.03 on September 12, 2025, to just $1.02 on September 15, marking a staggering loss of 83.2% in a matter of hours.

Key Dates and Next Steps for Shareholders

Shareholders impacted by this situation should note that the deadline to register as lead plaintiffs in this class action is December 8, 2025. Those awaiting updates on their case can register, and upon doing so, will be provided with status notifications through a portfolio monitoring tool throughout the lifespan of the case.

Why Choose The Gross Law Firm?

The Gross Law Firm is a nationally recognized firm focused on protecting investors’ rights who have faced losses due to misleading corporate practices and fraudulent behavior. Their mission emphasizes holding negligence accountable within the corporate world. The firm is dedicated to negotiating resolutions that right the wrongs caused to defrauded shareholders.

The law firm's extensive experience in handling class actions underlines their commitment to ensuring companies are held accountable for their statements and the ramifications these statements have on shareholders and market integrity. Should you wish to participate in this case at no cost or obligation, you are encouraged to visit their official webpage for further assistance and registration.

In conclusion, if you are an aTyr shareholder who purchased shares during the outlined period, immediate action is advised to capitalize on your rights regarding this class action. The Gross Law Firm is set to navigate this litigation, seeking justice for investors affected by this incident.